Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-003700
Filing Date
2021-08-16
Accepted
2021-08-16 16:03:55
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 30, 2021 sonoma_i10q-063021.htm   iXBRL 10-Q 649476
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES sonoma_10q-ex3101.htm EX-31.1 8470
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES sonoma_10q-ex3102.htm EX-31.2 8353
4 CERTIFICATION OF OFFICERS PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUAN sonoma_10q-ex3201.htm EX-32.1 4513
  Complete submission text file 0001683168-21-003700.txt   3921256

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20210630.xsd EX-101.SCH 30265
6 XBRL CALCULATION FILE snoa-20210630_cal.xml EX-101.CAL 58645
7 XBRL DEFINITION FILE snoa-20210630_def.xml EX-101.DEF 131508
8 XBRL LABEL FILE snoa-20210630_lab.xml EX-101.LAB 293579
9 XBRL PRESENTATION FILE snoa-20210630_pre.xml EX-101.PRE 240835
10 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-063021_htm.xml XML 472428
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 211177823
SIC: 2834 Pharmaceutical Preparations